An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15. 2018

Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
Department of Cytogenetics and Molecular Pathology, Locus Medicus S.A, Athens, Greece.

This is a case report of a 46-year-old man diagnosed with early pre-B acute lymphoblastic leukemia (ALL), bearing the translocation t(12;17)(p13;q21) as the sole chromosomal abnormality. This is a rare chromosomal abnormality that has been reported in approximately 25 cases worldwide. FISH analysis revealed a rearrangement of ZNF384 (12p13) and TAF15 (17q12) genes, which is usually associated with a pre-B ALL phenotype with co-expression of the myeloid markers CD13 and/or CD33. ZNF384 encodes a zinc finger protein, which acts as a transcription factor, regulating the expression of several matrix metalloproteinases and TAF15 belongs to the FET (FUS, EWS, and TAF15) family, consisting of RNA and DNA-binding proteins. Unlike most of the cases where CD10 expression was absent or weak, in our case CD10 was highly expressed. The prognostic significance of ZNF384/TAF15 fusion is not very clear since several reports support a generally good prognosis, while others support a poor clinical outcome. Our patient was treated with the German multicenter ALL (GMALL) protocol for B-ALL, but experienced a fulminant gram-negative sepsis and eventually died during induction therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D002871 Chromosome Banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. Banding, Chromosome,Bandings, Chromosome,Chromosome Bandings
D002881 Chromosomes, Human, Pair 12 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 12
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015452 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia. Leukemia, Pre-B-Cell,Pre-B-Cell Leukemia,Pre B-ALL,Pre-B ALL,Precursor B-Cell Lymphoblastic Leukemia,Precursor B-Cell Lymphoblastic Lymphoma,Leukemia, Pre B Cell,Leukemias, Pre-B-Cell,Pre B ALL,Pre B Cell Leukemia,Pre-B-Cell Leukemias,Precursor B Cell Lymphoblastic Leukemia,Precursor B Cell Lymphoblastic Leukemia Lymphoma,Precursor B Cell Lymphoblastic Lymphoma

Related Publications

Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
July 2016, Annals of laboratory medicine,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
January 2016, Cytogenetic and genome research,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
April 1992, Leukemia,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
June 2010, The Korean journal of laboratory medicine,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
March 2011, Cancer genetics,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
August 2013, Leukemia & lymphoma,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
April 1988, Cancer genetics and cytogenetics,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
September 2022, The Gulf journal of oncology,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
February 2006, Cancer genetics and cytogenetics,
Nikolaos Georgakopoulos, and Panagiotis Diamantopoulos, and Francesca Micci, and Nefeli Giannakopoulou, and Konstantinos Zervakis, and Aglaia Dimitrakopoulou, and Nora-Athina Viniou
July 1993, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!